Executive Vice President and Head of Quality Assurance
David Fryrear, M.S., is Executive Vice President and Head of the Quality Assurance for Astellas. He has responsibility for providing the global vision, leadership and strategic direction for Quality Assurance, from the earliest stages of research through clinical development and commercialization.
David joined Astellas in 2019 as Division Head of Clinical and Research Quality Assurance (CRQA), leading the strategic direction of CRQA in evolving the organization’s model of enhancing agility and effectiveness. Prior to Astellas, David has held a number of senior positions in quality leadership at AbbVie and Eli Lilly and Company.
David earned his M.S. at Butler University College of Pharmacy and Health Sciences, Indianapolis where he Majored in Pharmaceutics.